ChemoCentryx, Inc.
CCXI
CCXI was delisted on the 19th of October, 2022.
193 hedge funds and large institutions have $3.04B invested in ChemoCentryx, Inc. in 2020 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 86 increasing their positions, 43 reducing their positions, and 15 closing their positions.
213% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 15
100% more repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 43
72% more capital invested
Capital invested by funds: $1.77B → $3.04B (+$1.27B)
54% more call options, than puts
Call options by funds: $118M | Put options by funds: $76.8M
19% more funds holding
Funds holding: 162 → 193 (+31)
42% less funds holding in top 10
Funds holding in top 10: 12 → 7 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$261M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$75.8M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$50M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$35.4M |
| 5 |
State Street
Boston,
Massachusetts
|
+$35M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$41.2M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$32.2M |
| 3 |
EP
Eversept Partners
New York
|
-$29.3M |
| 4 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$24.1M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$17.7M |
CCXI Hedge Fund Activity: Q2 2020 in Review
193 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q2 2020, worth a combined $3.04B — up 72% from $1.77B a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new CCXI positions and 15 closed out — a net gain of 32 holders — while 86 added to existing stakes and 43 trimmed.
The largest buyer was Wellington Management Group, opening a new position worth an estimated $261M. The largest seller was UBS Group, cutting an estimated $41.2M.
- 193 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q2 2020, up from 162 in Q1 2020.
- Funds reported $3.04B of ChemoCentryx, Inc. stock for Q2 2020, up 72% quarter-over-quarter.
- 47 funds opened new ChemoCentryx, Inc. positions in Q2 2020 and 15 closed out, a net change of +32 holders.
- The largest ChemoCentryx, Inc. buyer in Q2 2020 was Wellington Management Group, an estimated $261M added.
- The largest ChemoCentryx, Inc. seller in Q2 2020 was UBS Group, an estimated $41.2M sold.
Based on aggregated 13F filings for Q2 2020.